GOT2 and non-small cell lung carcinoma: Together, these findings suggest that miR-638/GOT2 is a downstream target of circ-SEC31A, and that circ-SEC31A promotes NSCLC progression by sponging miR-520a-5p, which increases GOT2 expression.